Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1984 1
1985 1
1987 1
1988 3
1989 2
1990 1
1992 1
1997 1
1998 1
1999 1
2000 4
2001 4
2002 2
2003 4
2004 9
2005 6
2006 7
2007 10
2008 21
2009 14
2010 17
2011 21
2012 27
2013 19
2014 14
2015 16
2016 25
2017 14
2018 29
2019 26
2020 31
2021 34
2022 29
Text availability
Article attribute
Article type
Publication date

Search Results

366 results
Results by year
Filters applied: . Clear all
Page 1
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial.
Davies M, Færch L, Jeppesen OK, Pakseresht A, Pedersen SD, Perreault L, Rosenstock J, Shimomura I, Viljoen A, Wadden TA, Lingvay I; STEP 2 Study Group. Davies M, et al. Among authors: viljoen a. Lancet. 2021 Mar 13;397(10278):971-984. doi: 10.1016/S0140-6736(21)00213-0. Epub 2021 Mar 2. Lancet. 2021. PMID: 33667417 Clinical Trial.
A comprehensive scientific overview of Garcinia cambogia.
Semwal RB, Semwal DK, Vermaak I, Viljoen A. Semwal RB, et al. Among authors: viljoen a. Fitoterapia. 2015 Apr;102:134-48. doi: 10.1016/j.fitote.2015.02.012. Epub 2015 Feb 27. Fitoterapia. 2015. PMID: 25732350 Review.
Renal stones.
Viljoen A, Chaudhry R, Bycroft J. Viljoen A, et al. Ann Clin Biochem. 2019 Jan;56(1):15-27. doi: 10.1177/0004563218781672. Epub 2018 Jun 13. Ann Clin Biochem. 2019. PMID: 29792045 Review.
HEART UK consensus statement on Lipoprotein(a): A call to action.
Cegla J, Neely RDG, France M, Ferns G, Byrne CD, Halcox J, Datta D, Capps N, Shoulders C, Qureshi N, Rees A, Main L, Cramb R, Viljoen A, Payne J, Soran H; HEART UK Medical, Scientific and Research Committee. Cegla J, et al. Among authors: viljoen a. Atherosclerosis. 2019 Dec;291:62-70. doi: 10.1016/j.atherosclerosis.2019.10.011. Epub 2019 Oct 14. Atherosclerosis. 2019. PMID: 31704552 Free article. Review.
Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial.
Lingvay I, Catarig AM, Frias JP, Kumar H, Lausvig NL, le Roux CW, Thielke D, Viljoen A, McCrimmon RJ. Lingvay I, et al. Among authors: viljoen a. Lancet Diabetes Endocrinol. 2019 Nov;7(11):834-844. doi: 10.1016/S2213-8587(19)30311-0. Epub 2019 Sep 17. Lancet Diabetes Endocrinol. 2019. PMID: 31540867 Clinical Trial.
Erratum.
Liu S, Li J, Zhang Y, Liu N, Viljoen A, Mostert D, Zuo C, Hu C, Bi F, Gao H, Sheng O, Deng G, Yang Q, Dong T, Dou T, Yi G, Ma LJ, Li C. Liu S, et al. Among authors: viljoen a. New Phytol. 2020 Dec;228(6):2004. doi: 10.1111/nph.16718. Epub 2020 Jul 9. New Phytol. 2020. PMID: 33459356 Free PMC article. No abstract available.
366 results